S2520
Lowering Prescription Drug Costs
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed House
- To Governor
- Became Law
Bill overview
This amendment seeks to lower prescription drug costs in Massachusetts by requiring the state’s Department of Public Health to negotiate drug prices with pharmaceutical manufacturers. It aims to increase transparency in drug pricing and potentially reduce the cost of medications for patients. The amendment is attached to an appropriations bill for the fiscal year 2026.
Key provisions
- Requires the Department of Public Health to negotiate drug prices.
- Promotes transparency in drug pricing.
- Focuses on reducing the cost of medications for Massachusetts residents.
Who is affected
- Patients in Massachusetts
- Pharmaceutical manufacturers
- The Department of Public Health
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cindy F. Friedman
Cosponsors
Cindy F. Friedman
Cynthia Stone Creem
Jason M. Lewis
Joan B. Lovely
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.
Amendment S.2520 194th (Current)
Senate, May 20, 2025 -- Text of amendment (541) (offered by Senator Friedman) to the Ways and Means amendment (Senate, No. 3) to the House Bill making appropriations for the fiscal year 2026 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements.
View Text Print Preview Download PDF
Bill Information
Bill Information
Sponsor: Cindy F. Friedman
Tabs
Amendment History Cosponsors
Bill History
Displaying 1 action for Bill S.2520
| Date | Branch | Action |
| 5/20/2025 | Senate | See S3 |
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.